Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients

计划入组 495 人 · 首次发布于 2023 年 9 月 21 日

Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?

计划入组 140 人 · 首次发布于 2021 年 9 月 21 日

Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy

计划入组 64 人 · 首次发布于 2024 年 8 月 16 日

CDK 4/6 inhibitors (pancreatic cancer)

Myrtleciclib

CDK-4/6 inhibitor (rheumatoid arthritis)

6'Naps

Belgium

October 6 University

Egypt

Ningbo No.6 Hospital

China

Abemaciclib Shows Promise in ER+/HER2- Advanced Breast Cancer Treatment

Ribociclib Shows Promise in Advanced Breast Cancer Treatment

Advances in Immunotherapy and Precision Medicine Transform Endometrial Cancer Treatment